A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG 3095)

15051MK-2870-005-GOG-3095Open (affiliates only)A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG 3095)MK2870-005 (GOG 3095)NCT06132958IndustrialAdultTreatmentIIIGlobalCervixHoskins, EbonyMedstar Washington Hospital Center : Shelley CollinsGyn. Onc.Oncology GroupMHRI Washington Cancer Institute13603Shelley CollinsShelley CollinsShelley.R.Collins@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>